Use of extracorporeal membrane lung assist device (Novalung) in H1N1 patients

Journal of Cardiac Surgery

Volumn 26, Issue 4, 2011, Pages 449-452

  Johnson, Philip ^a   Fröhlich, Stephen ^b   Westbrook, Andrew ^c  

^a ST JAMES S HOSPITAL   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c Midland Regional Hospital Mullingar   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBON DIOXIDE; DROTRECOGIN; HEPARIN; HYPERTENSIVE FACTOR; NITRIC OXIDE; OSELTAMIVIR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CASE REPORT; CONTINUOUS RENAL REPLACEMENT THERAPY; DEATH; DEVICE SAFETY; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; FUNGEMIA; HEMATOTHORAX; HEMODIAFILTRATION; HUMAN; HYPERCAPNIA; HYPOXEMIA; HYPOXIA; INFLUENZA A (H1N1); INSPIRATORY CAPACITY; LUNG COMPLIANCE; MALE; MEDICAL INSTRUMENTATION; MYCOBACTERIOSIS; NASOPHARYNGEAL ASPIRATION; NEUROMUSCULAR BLOCKING; NOSE SMEAR; PARTIAL THROMBOPLASTIN TIME; PH; PUMPLESS ARTERIOVENOUS EXTRACORPOREAL CARBON DIOXIDE REMOVAL DEVICE; RESPIRATORY ACIDOSIS; SHOCK; VENTILATOR;

ADULT; ARTIFICIAL ORGANS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; HYPERCAPNIA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

EID: 79961030483     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2011.01261.x     Document Type: Article

References (10)

1. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-1308.
2. ANZIC Influenza Investigators: Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 361 (20): 1925-1934.
3. Rello J, Rodríguez A, Ibañez P, et al: Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 2009; 13 (5): R148.
4. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators: Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302 (17): 1888-1895.
5. Freed DH, Henzler D, White CW, et al: Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010; 57 (3): 240-247.
6. Hammell C, Forrest M, Barrett P,: Clinical experience with a pumpless extracorporeal lung assist device. Anaesthesia 2008; 63 (11): 1241-1244.
7. Ricci D, Boffini M, Del Sorbo L, et al: The use of CO2 removal devices in patients awaiting lung transplantation: An initial experience. Transplant Proc 2010; 42 (4): 1255-1258.
8. Walles T,: Clinical experience with the iLA Membrane Ventilator pumpless extracorporeal lung assist device. Expert Rev Med Devices 2007; 4: 297-305. (Pubitemid 46845742)
9. Das Einsparpotenzial innovativer Medizintechnik im Gesundheitswesen 2010. ISBN 978 3-941502-07-9 1st edition/Berlin, November 2010.
10. Peek GJ, Elbourne D, Mugford M, et al: Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess 2010; 14 (35): 1-46.